Peptron, Inc. (KOSDAQ:087010)
286,000
+34,000 (13.49%)
Nov 7, 2025, 3:30 PM KST
Peptron Market Cap
Peptron has a market cap or net worth of 6.67 trillion as of November 10, 2025. Its market cap has increased by 334.49% in one year.
Market Cap
6.67T
Enterprise Value
6.58T
Revenue
5.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
286,000.00
Market Cap Chart
Since July 22, 2015, Peptron's market cap has increased from 211.83B to 6.67T, an increase of 3,048.21%. That is a compound annual growth rate of 39.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 6.67T | 181.18% |
| Dec 30, 2024 | 2.37T | 185.66% |
| Dec 28, 2023 | 830.23B | 426.14% |
| Dec 29, 2022 | 157.80B | -31.08% |
| Dec 30, 2021 | 228.96B | -8.91% |
| Dec 30, 2020 | 251.35B | -16.11% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.09T |
| ALTEOGEN | 28.24T |
| SK Biopharmaceuticals | 9.08T |
| Yuhan | 8.62T |
| HLB Co., Ltd. | 6.25T |
| ABL Bio | 5.58T |
| Hanmi Pharm. | 5.57T |